vaccines and global health :: ethics and policy

….from the Center for Vaccine Ethics and Policy…GE2P2 Global Foundation

Menu

Skip to content

Home
about us
ethics & policy consulting
- CVEP: Fiduciary Transition [May-June 2015]
week in review
- #53112 (no title)
symposium resources
keynotes, papers, panels
- Observations and Comment :: Beware of Kingdoms bearing Gifts – Gavi, Yemen and $25 million from Saudi Arabia :: 3 Nov 2016

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Posted on 15 December 2021 by davidrcurry

New England Journal of Medicine
December 9, 2021 Vol. 385 No. 24
http://www.nejm.org/toc/nejm/medical-journal

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar H. Chemaitelly and Otherse

Share this:

Facebook
X

Like Loading...

Related

This entry was posted in Uncategorized. Bookmark the permalink.

Post navigation

← Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents →

Search

Archives

Meta

Create account
Log in

Blog at WordPress.com.

Reblog
Subscribe Subscribed
- vaccines and global health :: ethics and policy
- Already have a WordPress.com account? Log in now.

%d